SCHEMBL3010271

SCHEMBL3010271

CCC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@H]3OC(C)(C)O[C@]32C(=O)CO)[C@@H]2C[C@H](F)C3=CC(=O)C=C[C@]3(C)[C@H]21

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 9/20 0.76
▸ PGR P06401 8/20 0.76
▸ CYP3A4 P08684 6/20 0.76
▸ LMNA P02545 6/20 0.76
▸ ABCB11 O95342 4/20 0.76
▸ HSD17B10 Q99714 3/20 0.76
▸ KDM4E B2RXH2 2/20 0.76
▸ CYP2C19 P33261 1/20 0.76
▸ HTR1A P08908 1/20 0.76
▸ ADRA2A P08913 1/20 0.76
▸ ADRA1A P35348 1/20 0.76
▸ HIF1A Q16665 6/20 0.56
▸ AR P10275 5/20 0.56
▸ MAPT P10636 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.48
▸ MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL42575 0.92 NR3C1 (0.78) NR3C1PGRCYP3A4LMNAABCB11
Flunisolide SCHEMBL4351 0.86 CYP3A4 (1.00) NR3C1PGRCYP3A4LMNAABCB11
Flunisolide SCHEMBL66051 0.86 CYP3A4 (1.00) NR3C1PGRCYP3A4LMNAABCB11
Flunisolide SCHEMBL30994800 0.86 CYP3A4 (1.00) NR3C1PGRCYP3A4LMNAABCB11
Flunisolide SCHEMBL5187487 0.86 CYP3A4 (1.00) NR3C1PGRCYP3A4LMNAABCB11
Flunisolide SCHEMBL8810954 0.86 CYP3A4 (1.00) NR3C1PGRCYP3A4LMNAABCB11
Flunisolide SCHEMBL13026142 0.86 CYP3A4 (1.00) NR3C1PGRCYP3A4LMNAABCB11
Flunisolide SCHEMBL5493687 0.86 CYP3A4 (1.00) NR3C1PGRCYP3A4LMNAABCB11
Flunisolide SCHEMBL13662143 0.86 CYP3A4 (1.00) NR3C1PGRCYP3A4LMNAABCB11
Flunisolide SCHEMBL13602384 0.86 CYP3A4 (1.00) NR3C1PGRCYP3A4LMNAABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295489-A Compositions, devices and methods for treating respiratory disorders 呼吸解决方案股份有限公司 2023-12-26 — — CN claimed
CN-117279681-A Product delivery device and method 呼吸解决方案股份有限公司 2023-12-22 — — CN claimed
CN-117295489-A Compositions, devices and methods for treating respiratory disorders 呼吸解决方案股份有限公司 2023-12-26 — — CN disclosed
CN-117279681-A Product delivery device and method 呼吸解决方案股份有限公司 2023-12-22 — — CN disclosed
CN-116133664-A Ophthalmic inserts containing glucocorticoids 视觉治疗股份有限公司 2023-05-16 — — CN disclosed
CN-110177780-B Pyrimidine compounds containing acidic groups 阿普罗斯治疗公司 2022-11-01 — — CN disclosed
US-20100191215-A1 PRESSURE PULSE ACTUATING DEVICE FOR DELIVERY SYSTEMS BY-PASS ,INC. (US) 2010-07-29 — — US disclosed
WO-2008152639-A2 PRESSURE PULSE ACTUATING DEVICE FOR DELIVERY SYSTEMS BYPASS, INC. (US) 2008-12-18 — — WO disclosed
EP-1549371-A2 NEBULIZER HAVING A SOLVENT AND AN INERT SUBSTRATE IMPREGNATED WITH A PHARMACEUTICAL INGREDIENT Collegium Pharmaceutical, Inc. (US) 2005-07-06 — — EP disclosed
WO-2004022132-A2 NEBULIZER HAVING A SOLVENT AND AN INERT SUBSTRATE IMPREGNATED WITH A PHARMACEUTICAL INGREDIENT COLLEGIUM PHARMACEUTICAL, INC. (US) 2004-03-18 — — WO disclosed
US-20040045546-A1 Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use PEIRCE MANAGEMENT, LLC 2004-03-11 — — US disclosed
Send feedback